Powered by the innovation that made us a leader in Life Sciences
Dates coming soon
Dates coming soon
Illumina sequencing is fueling groundbreaking discoveries across a wide range of research areas. By enabling the broadest range of applications including whole-genome resequencing, de novo sequencing, targeted resequencing, transcriptome and epigenetic analysis, researchers are publishing at amazing rates.
This seminar series will showcase presentations from scientists using Illumina technology to power their next-generation sequencing studies. We invite you to join us, learn about their research, and receive an update on new sequencing products from Illumina.
Up to 50% more coverage of common and rare variants. Maximum power for any population. Multiple product paths and flexible points of entry. Always the latest content. It's Next-gen GWAS with the whole genome in mind.
At this seminar series, learn how the Omni family of microarrays can empower you to reach your ultimate research goals. Listen in as researchers from around the world present their work using Illumina microarray technology, while also having a chance to network with industry colleagues and receive updates from Illumina staff.
Global issues. Genetic answers. Rapid population expansion on a finite amount of land. It's at the core of our planet's challenges. Getting the most out of agriculture. Minimizing environmental impact. Use Illumina's advanced genetic analysis tools to meet these challenges. Discover more. Validate selections. Screen for the traits that will make a difference.
At this seminar series, you'll hear compelling presentations from scientists using Illumina technology to expand their research and perform the studies they only dreamed of a few years ago. With the industry's most comprehensive genetic analysis tool set, we're here to provide the power you need. Power to find the most desirable traits. It's time for a new evolution in genetic research.
Powered by the innovation that made us a leader in Life Sciences, IlluminaDx is dedicated to developing the next generation of molecular tests, systems and services that enable earlier diagnosis, selection of appropriate therapies and monitoring of disease progression. Our vision is to become a leader in translational medicine, focusing on complex diseases that benefit from high performance analysis, including genotyping, copy number, gene expression, methylation and protein analysis.
In this seminar series, you will have the opportunity to learn how IlluminaDx is leveraging the strength of our technologies in four major areas: